EyeNet Magazine
Current ROP Therapies: How Laser and Anti-VEGF Compare

With the publication of the BEAT-ROP study results in 2011, some clinicians were inclined to jump on the bevacizumab bandwagon, while others held back, citing the well-documented success of laser.

What have we learned since then?

___________________________

EyeNet introduces its brand new mobile-optimized digital edition all the benefits of the print edition, plus digital enhancements.

Read on a break at work, kicking back at home with our iPad, or on your phone while in line at the grocery store. Check it out.

 
 
 
Multimedia Extra: Descemet's Membrane Endothelial Keratoplasy

In the slideshow above, Arthur W. Giebel, MD, demonstrates how to perform DMEK surgery.

Read more. Interested in a step-by-step review of the procedure? This month's Cornea Clinical Update covers everything from graft preparation to postoperative care.

 
 
 
 
February 2014 Blink
Blink
 
 
Morning Rounds

The Case of a Mysterious Mass and a Slipped Rod

One morning, the patient had a coughing fit in the shower, but he didn’t think much of it. When he got out of the shower, the 72-year-old retired engineer attempted to insert a contact lens into his right eye. He hadn’t worn the lens for eight months, and he immediately noticed that it felt uncomfortable and threw it away. When he carefully inspected his eye in the mirror, he noticed a white line along the inferior aspect of his iris. He thought this was odd and made an appointment to see us two days later.

What’s your diagnosis?

February 2014 Morning Rounds
 
 
Opinion

How Costly Is Blindness? We Ought to Know

Faced with competing priorities, Congress has been willing to fund everything that seemed deserving. Those free-spending days are coming to an end, and when they do, the proposals supported by the best data and the best lobbying efforts will have an advantage.

Although ophthalmology and the patients we serve have excellent lobbying on our behalf, our advocates need solid data to show that vision care and research are good investments of public funds.

February 2014 Opinion
 
 
WRITE TO US

We welcome letters on all issues raised in EyeNet, and on ophthalmology generally.

Share your thoughts with your colleagues by sending a letter to eyenet@aao.org.

 












About Us Academy Jobs Privacy Policy Contact Us Terms of Service Medical Disclaimer Site Index